Publikationen von Peter H. Seeberger
Alle Typen
Patent (33)
2017
Patent
Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)
Patent
Method for determining carbohydrates structure. (2017)
Patent
Process for the preparation of Efavirenz and devices suitable therefore. (2017)
2016
Patent
Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
Patent
Vaccine against carbapenem-resistant klebsiella pneumoniae. EP3274358 (2016)
Patent
Vaccines against Streptococcus pneumoniae serotype 4. EP3230297 (2016)
Patent
Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
Patent
Synthetic vaccines against Streptococcus pneumoniae serotype 8. (2016)
2015
Patent
Synthetic vaccines against Streptococcus pneumoniae. (2015)
Patent
Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives. WO2015007693 (2015)
Patent
Synthetic vaccines against Streptococcus pneumoniae type 1. (2015)
2014
Patent
Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis. EP2766024 A1 (2014)
Patent
Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics. (2014)
Patent
Synthesis of diverse glycosylphosphatidylinositol glycans and glycolipids from toxoplasma gondii and their application as diagnostic markers and vaccines. (2014)
2013
Patent
Carbohydrate-glycolipid conjugate vaccines. (2013)
Patent
Method and device for the synthesis of Artemisinin. EP2751113 (2013)
Patent
Polysaccharide antigen-glycolipid conjugate vaccines. EP2827899 (2013)
Patent
Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis. (2013)
Patent
Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)
2012
Patent
Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide PS-II, methods of synthesis and uses thereof, in particular as a vaccine. EP2683401 (2012)